Actively Recruiting
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
Led by Immunis.AI · Updated on 2026-04-02
2000
Participants Needed
1
Research Sites
524 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A multi-center, prospective active surveillance registry trial assessing the performance of a non-invasive blood test for indolent prostate cancer disease management.
CONDITIONS
Official Title
Active Surveillance SNEP Assay Registry Trial for Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men between 40-80 years of age with at least a 10-year life expectancy
- All active surveillance protocols are accepted
- No PSA limits
- Patient is currently on active surveillance with only ONE previous low grade prostate biopsy
- Patient must already be scheduled for their 1st annual biopsy under their active surveillance protocol within 90 days of enrollment date
- Patient is recently diagnosed with low grade prostate cancer but has decided against active surveillance and is scheduled for radical prostatectomy within 90 days of enrollment date
You will not qualify if you...
- Men on watchful waiting with less than 10-year life expectancy and no intent for curative therapy
- Men with symptoms or rising PSA who have not been proven to have cancer by tissue biopsy
- Patients with only negative prostate biopsies
- Patients with a history of a different cancer except basal cell carcinoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Comprehensive Urology
Royal Oak, Michigan, United States, 48197
Actively Recruiting
Research Team
J
Jessica DeHart
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here